What is Polaryx Therapeutics, Inc. 's total liabilities?

Polaryx Therapeutics, Inc. (PLYX) reported total liabilities of $1.01M in Q1 2026.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Polaryx Therapeutics, Inc. PLYX Total Liabilities

Total Liabilities at other companies

BioMarin PharmaceuticalsBMRN

$2.38B+75.8%

Zevra Therapeutics, Inc.ZVRA

$8.16M-93.8%

Eton Pharmaceuticals, Inc.ETON

$67.1M+12.6%

XER

Xeris Biopharma Holdings, Inc.XERS

$379M+8.1%

Relay Therapeutics, Inc.RLAY

$57.43M-26.6%

PVL

Palvella TherapeuticsPVLA

$31.45M+31.8%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's total liabilities?: Polaryx Therapeutics, Inc. (PLYX) reported total liabilities of $1.01M in Q1 2026.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.